Withdrawn: Circ‐SOX4 promotes non‐small cell lung cancer progression by activating the Wnt/β‐catenin pathway

DOI: https://doi.org/10.1002/1878-0261.12656

2020-11-15

Molecular Oncology

Abstract:<p>Non‐small‐cell lung carcinoma (NSCLC) accounts for the majority of lung cancer deaths, and thus there is a clinical need to understand the molecular mechanisms underlying this malignancy. Tumor‐initiating cells (TICs) have been accepted to be closely related to tumor reoccurrence after surgery, and circular RNAs (circRNAs) play a crucial function in the tumorigenesis and development of human cancers. Here, we examined the role of the circular RNA hsa_circ_0131457 (circ‐SOX4) in lung TICs. We report that circ‐SOX4 is upregulated and exists as a covalently closed loop structure in CD133⁺ cancer cells. Subsequent functional assays showed that circ‐SOX4 downregulation suppresses lung TIC proliferation, self‐renewal, migration and invasion. Circ‐SOX4 upregulation facilitates <i>in vitro</i> development of CD133^‐ cancer cells, and circ‐SOX4 deficiency represses <i>in vivo</i> malignancy of CD133⁺ cells. Additionally, circ‐SOX4 was shown to interact with c‐MYC by activating the Wnt/β‐catenin pathway in NSCLC. In summary, circ‐SOX4 expedites NSCLC progression by activating the Wnt/β‐catenin pathway, and this finding may facilitate the identification of effective therapeutic targets for NSCLC.</p>

oncology